Sunday, August 8, 2010

Have You See Something From The Thing

Medical science would certainly be a completely different course when, in 1895, Wilhelm Conrad R?ntgen was not discovered by accident in his experiments with vacuum tubes, can the radiation penetrates the strange object that bears his name in many parts of the world, and we call it, rather than the name given the elisa kit.Roentgen was given this name because it was for him a new radiation mysterious and unknown to us today are more serious and widespread ad-diagnostic tool.


Therefore, more radiology over the years, has involved not only the competence of doctors and technicians in its use, but also in the technologies it contains, and managing tools for the treatment of patients with imaging techniques.

confused by X-ray radiographs of the first images of bones in the hand of his wife, began a path that crosses the beam, so that the observation of dynamic processes inside the body where they occur, Tomography, a representation 3-D of the veins and arteries as possible resonance, magnetic, creating digital versions of an axis, leading to nuclear medicine for the control of physiological activity in the internal organs is possible. However, even today, in most cases, traditional radiography, speed thanks to its easy handling and cost realtively low, remains the most important diagnostic tool, especially in the development of technical devices. And speaking of equipment, probably the most important is the C-arm or the image intensifier. We spoke with an Italian company that was his design € Columbus since the 70s.

The C-arm is a complex piece of machinery used in radiology to examine patients. Its functions are not only "images" inside the body, but be realistic short films, which can be viewed in real time on the screen while an X-ray known address sad that in itself can not prevent: the lethality at high doses. If the name elisa kit comes directly from the shape of the tool, image converter, which is so important stems from the fact that this tool can improve the low dose X-ray that for a given is an accurate and well regulated from inside the patient's body. The benefits for the patient, which is bombarded by a much smaller amount of radiation, and the mark of several questions about elisa kitand still something important diagnostic tool is evident.

Image intensifiers are now used in a variety of tests: Fertility studies endoscopy, angiography, and cardiac and orthopedic tests. Possiiblity And thanks to the integration of digital systems, this device makes it possible to revise the examination film without the need for additional testing and the bombardment of radiation to zoom in real time, useful information on the clinical and distance measurements directly vascular taken in the exploration and reduction of the amount and duration of exposure to X-rays.

Kinds Of Health Insurance Policies

Health Insurance Policies have become rather costly these days as medical science has achieved huge successes, with a growing need for doctors all over the country. Over the last couple of years unprecedented advancements have been made in the field of medication that has given a boost to the health care industry in a very significant way.

All the latest inventions and discoveries have led to an advanced medical technology. However, there is a lot that had to be invested in the researches to bring ahead these pioneering breakthroughs which have created new grounds for a better living for mankind. Hence with all that put together, the prices of the health insurance policies are growing a little too expensive.




There are a number of other factors that contribute to the hyped prices. To name a few would be flawed legislations. This has led to embarrassing situations and the demand for immediate intervention of the Government of the United States of America to come ahead and take a part in the pricing process as far as insurance policies are concerned.



Federal organizations have taken up a significant role in the health care industry. They should do something similar to what has been already achieved in Canada, where the government provides a good amount of subsidy for the health care services of the entire population. This is why the insurance costs are low and within an affordable range.



Here is a list of the diverse range of health insurance policies available in the market.



1) Health Care Insurance based on Employment: A private health care insurance is like a health plan that is provided to each of the employees by the employer or the labor union. This is particular kind of insurance that is provided by the employing company and is bought from a private company that sells health care insurances.



2)Health Care Insurance plans that are directly purchased: This is a health coverage plan that is purchased personally by an individual from a private health care insurance provider. These insurances come with different levels of coverage. Nowadays a lot of insurance companies are also providing policies for people from lower economic backgrounds. However, the primary category that the insurance companies deal with is the policies which come with the increased monthly premiums.



3)Government Health Care Insurance Policy: The health care insurances provided by the government of the United States are distributed on all the federal, state and local levels. These are coverage plans provided under the insurance schemes sponsored by the Government. The most common ones are the Medicaid, Medicare, SCHIP and the Military health care plans. People who luckily qualify for these insurances may rest assured as the government bears a considerable sum of their expenses whenever necessary.



4)Specific Insurance Plans provided by the state: These insurance plans, as the name suggest, are sponsored by the individual states in the US. This is a special health coverage plan that is given out by the state office to its many constituents and is termed under different names in different states.

Thursday, August 5, 2010

Genital Wart Removal Techniques - Which Techniques Are Most Effective For Removing Your Genital Wart

If Conventional Methods Fail To Remove My Genital Warts, What, If Any, Are My Options?




It comes as no surprise that after utilizing some of the more conventional methods of removing your genital warts you are still looking for a more permanent removal solution. Other more drastic options include such techniques as CO2 laser surgery, where the doctor takes a laser and burns the warts off of the skin over the course of a series of visits. This can be quite expensive, time consuming, painful and frankly, quite frightening as anyone can imagine. Another treatment which uses similar directness in genital wart removal is cryotherapy. This also involves a series of visits, during each of which the doctor directly applies liquid nitrogen to the warts, freezing them off from the skin. Then there is the Loop Electrosurgical Excision Procedure (LEEP), which utilizes a bladed tool, the blade being loop-shaped. This is passed around and under each wart in order to carve them away from the skin.



Currently, Removal Of Genital Warts Using Medical Techniques Are Expensive, Cause An Increase in Stress Levels And Can Be Quite Painful. At Least There's A Guarantee They Won't Return Right?



Now, these methods, though somewhat drastic-seeming in concept, do actually result in complete genital wart removal. The only problem besides the cost, stress and pain is that this does not guarantee anything against the inevitable - the recurrence of more warts in the near future. So to recap, a person may start with easily acquired topical remedies, then move on to prescription topical medications, and eventually may undertake the more drastic methods of topical genital wart removal. Are you beginning to see a pattern here?



This is the way of allopathic medicine, today's modern medical science. It tends to attack the outward symptoms, but fails to go after the internal cause. All this medical science can do is dull the effects of ailments with chemicals and drugs, or cut something off of the body. Granted, there are times when such practices can save a life, such as when a limb becomes gangrenous and needs to be amputated, but as far as curing the causes of our ills, this would be a mite like swatting at a fly with a howitzer. It's just overkill.



Is Herbal Remedies, Homeopathic And Naturopathic Medicine The Natural Cure To Removing Genital Warts?



This is why many sufferers have turned their attentions to naturopathic and homeopathic methods of healing and medication. To properly and more effectively rid ourselves of the nagging symptoms of various maladies is to eliminate the cause, thusly eradicating the problem in its entirety. So what would be this cause in this case? That would be HPV (Human Papilloma Virus) - this is a sexually transmitted virus, the symptoms of which can be elusive in the primary stages. In fact, symptoms can show up as soon as a couple of weeks, or may not become plainly present even for a few years. It is always recommended to see a doctor regularly for checkups in order to catch this, or any disease, in its earliest stages.



So how does one go about controlling this virus? This can most effectively be done using natural herbal medications such as medicinal plant extracts and essential oils. Being lipophilic in nature, these medicines when applied topically get immediately absorbed through the skin and are directly taken into the bloodstream where the treatment can do its work to combat this virus. Those who use this technique, depending upon the severity of their condition, achieve complete results within 2-8 weeks, ending with the warts being starved from within, flaking off the skin never to return. This is how to go about the task of real, permanent genital wart removal, naturally, effectively and permanently

The Ethics Of Phase 1 Research In Patients


Phase 1 trials are the gatekeeper of clinical research as they are often the first time a potential new drug treatment enters humans ( First-in-Man or FIM trials). In the past FIM trials usually enrolled between 20 and 80 healthy volunteers carefully screened for the absence of disease and in part paid for trial participation. However, this is no longer the case. Due to recent concerns over drug safety – for example the Northwick Park experience with TGN1412 causing serious adverse reactions in healthy volunteers - and with the advance of medical science leading to the development of treatments with greater specificity Phase 1 research now increasingly considers patients.




The involvement of patients brings a new dimension to research; patients can conceivability benefit from clinical trials and in considering entering a clinical trial both the patients and the attending doctor must consider the alternatives of treatment. For this latter reason, perhaps, many clinical trials involving patients only consider the terminally ill as candidates for the clinical trials. The perception of benefit also means that patients in Phase 1 clinical trials are not paid. There are also ethical considerations when considering the enrolment of patients. In the conduct of medical care the free will or autonomy of the patient is seen as prime. Failure to respect the wish of patients in deciding their treatment is seen as morally wrong, and in most countries subject to legal sanction. Coupled with the demands of autonomy, and in support of it, are the requirements to fully inform patients about the potential effects of treatment and the alternatives available. Balancing these roles and responsibilities on the medical profession are the requirements that doctors should do no harm and also ensure the just use of resources. These ethical principles are enshrined in the ethical principles of deontology. In this school of ethical thought it is the intentions not the outcomes that determine morally acceptable behaviour. For example if you have acted in a way that respected patient autonomy, and fully informed them of the outcomes of choices, and the patient has a bad outcome, you have still acted in a morally acceptable manner. In contrast scientific research has a different ethical perspective. It is the magnitude of the outcome that matters in Phase 1 research in order to select a dose for a subsequent trial or the determination of a toxic dose (Shamoo, 2008). Another factor in the conduct of research is that the results should be generalisable to a population of patients in order to extrapolate the meaning of results. In this instance the intention is not to select a treatment for an individual patient. The focus on the outcome of the clinical trial, and the intention to gather generalisable information gives the ethics of clinical research – and Phase 1 clinical research in particular – a so called consequentialist approach. Consequentialist ethics are concerned with the outcome of an action, rather than the intention of the action. Perhaps the best known consquentialist approach is utilitarianism – acting in a way that leads to the benefit for the greatest number. Phase 1 research is often said to be utilitarian in nature as it seeks generalisable knowledge.



The deontological and consequentialist and approaches often lead to different definitions of what is morally correct and acceptable. Consider this. You are standing at a bus stop when a man comes up to you and says he is being chased by an axe murderer. He says he is going to hide in the bushes till the person passes and does so. A few minutes later a man carrying an axe runs up and asks if you have seen anybody, what do you do?



As a consequentialist, you would say you saw nobody as the consequences of your action would lead to murder.



As a deontologist in a strict sense you would say he is in the bushes as it is always morally wrong to deceive anybody!

The conflict between the deontological approaches of medical practice and the utilitarian perspective of clinical research in Phase 1 has lead some ethicists to conclude that it is not ethical to enrol patients in Phase 1 studies. The foundation of this claim is that as these are patients their care is paramount, and patients cannot exercise autonomy in their choice as

1. Phase 1 clinical trials causes more harm to patients than potential benefits.

2. Patients cannot provide a valid informed consent, as they are not consenting for themselves but the collection of generalisable information.

3. Patients whom are terminally ill are vulnerable and so are liable to be manipulated.



Taking these factors in turn:



1. Phase 1 clinical trials causes more harm to patients than potential benefits.



This statement leads to another question – more harm that what or more benefit than what? Both the deontological and consequentialist approaches to medical ethics requires careful consideration of the risks and potential benefits of a medical intervention be it an operation or a clinical trial. In making an assessment of the intervention it is usual to have some form of comparator. In Phase 1 clinical trials three methods have been used. The first is to compare it to the alternative of palliative care – particularly in cancer, but also in inflammatory diseases. The second way of comparing risks and benefits is to look at the approved cancer treatments and draw parallels with the currently licensed medications available from the FDA or the European regulators. The third is to draw parallels with the use of off label medications in cancer (Joffe & Miller, 2006).



The use of a comparison to palliative care is not valid. The patients whom enter a Phase 1 clinical trial have already rejected it as an option at the moment they enrol in a clinical trial. In addition they have not rejected it in the future by enrolling in a trial.



A comparison to existing treatments is also misleading. Many Phase 1 patients have exhausted treatment options so marketed treatments are not a valid comparison. In addition drugs on the marketplace are often registered on the basis of different clinical outcomes than those being measured in clinical trials. Finally as 90% of drugs fail in the development process, the use of a benchmark to existing drugs sets a very high barrier.



Instead perhaps it is more valid to consider the risks and benefits of enrolling in a clinical trial against the use of off label medication by doctors and patients. In this case the treatment population is the same – both patients enrolling in clinical trials and those wanting to use off label treatments have rejected palliative care in the first instance. In addition of label use outcomes are often expressed in terms of anecdotal outcomes rather than registration endpoints. The problem is that this data is hard to obtain. However, what is known in the field of oncology is that approximately 4% of patients have meaningful clinical endpoint outcomes in Phase 1 trials (Joffe & Miller, 2006). This contrasts with the reported rate of toxicity death rates of 0.5% (Addoler, Taylor, & Wendler, 2008). These figures argue against the proposal that Phase 1 clinical trials in patients cause harm, as in the population that enrol in clinical trials have risks and benefits comparable to off label use of existing drugs (Joffe & Miller, 2006).



A second argument for the fact that patients suffer harms in Phase 1 clinical trials is that the usual outcomes cannot measure harm, and that the harms are best expressed in terms of Quality of Life (Qol). The harm it is argues is a decline in Qol due to clinic visits and procedures. There is little data available on this aspect, but what does exist suggests that many patients Qol is not changed by enrolment in a Phase 1 clinical trial as the majority of these trials are short in duration (Addoler, Taylor, & Wendler, 2008).



Based on these findings it is difficult to argue convincingly that the risks and benefit balance of Phase 1 clinical trials in patients are better or worse than the alternatives, and therefore to argue that their exclusion from Phase 1 trials can be justified on the trials cause harm.



2. Patients cannot provide a valid informed consent, as they are not consenting for themselves but the collection of generalisable information.



The foundation to this objection is that patients do not appreciate or understand that they are participating in clinical research, and do not receive or perceive the information they are given and therefore informed consent is not valid.



Empirical studies cast doubt on this assertion (Addoler, Taylor, & Wendler, 2008). Interviews with patients enrolling into clinical trials have shown that the majority of subjects do understand the nature of the trial into which they are enrolling, albeit the primary motivation for enrolment was the hope of some benefit.



Of greater concern in the process of informed consent is the issue of voluntariness. In other words that the participation in a clinical trial stems from pressure from a physician whom is also acting as an investigator. There is some evidence that doctors over-estimate the chances of benefit from clinical trials mostly unintentionally (Addoler, Taylor, & Wendler, 2008). However, in interviews with patients, the role of physician advice in enrolling in trials appeared to be low.



On the other hand the fact that patients cannot give informed consent to enter into clinical trials also seems weak.



3. Patients whom are terminally ill are vulnerable and so are liable to be manipulated.



This argument is closely related to the other two objections, and suggests that as patients are unable to assess risks and benefits and give full consent they are vulnerable to manipulation. This argument also does not stand up to empirical analysis. Studies have indicated that the population that enrol into clinical trials are not economically or socially disadvantaged (Addoler, Taylor, & Wendler, 2008). Furthermore, other wishes of terminally ill patients are often respected in terms of Advance Directives. So it is hard to argue that the patients whom enrol in trials are vulnerable.



Conclusions

This review has made the argument that patients should be enrolled in Phase 1 clinical trials, as it enrolment in a trial appears to do them no harm, and could provide benefit no worse than other interventions. Arguments that these patients cannot consent, or are too vulnerable are not valid objections to patient enrolment.



This conclusion has some impact, for in many aspects it argues that patients and healthy volunteers face identical ethical issues in their participation in Phase 1 research. This begs the question, should we not pay patients for enrolling in Phase 1 research. It is hard to argue against if we accept that the ethical dilemmas are identical.

What the review has highlighted is that there is a genuine concern over the voluntary nature of consent in clinical research in phase 1, and there may be a need to redefine the doctor patient relationship in circumstances where a physician is also an investigator. It may be a necessity to put in other patient safeguards such as other doctors or nurses besides the investigator obtaining the informed consent.





Bibliography

Addoler, E., Taylor, H., & Wendler, D. (2008). The Ethics of Phase 0 Oncology Trials. Clinical Cancer Rees , 14, 3962-3967.

Joffe, S., & Miller, F. (2006). Rethinking the Risk Benefit for Phase 1 Cancer Trials. J Clin Oncol , 19, 2987-2990.

Shamoo, A. (2008). The Myth of Equipose in Phase 1 Trails. The Medscape Journal of Medicine , 10, 254

How To Make A Timeline Science Project


What Is a Timeline Study?




A timeline study is what scientists refer to as a longitudinal study. This type of study measures changes that occur within a study population over a period of time. Since students generally have a limited amount of time to develop a science fair project, timeline projects are going to evolve from year to year.



First Year Timeline Study



The first year that you work on your timeline science project is going to involve the most work. During this year you will be setting up your hypothesis, your experiment and selecting your test population. You will also need to collect baseline data from your test population. This information will be used to compare test results to after each year.



Second Year Timeline Study



The second year in your timeline science project is going to be pretty easy. The main components of your project have all ready been established. Your only really work will be to collect data on your test population and to compare it against the data collected in your first year. You will need to illustrate the data changes in graphs and charts.



Third Year Timeline Study



By the third year of your timeline study you will basically doing the same thing that you did in year two. However, this year you will have more data to work with so you will be starting to see trends in the changes to your selected variables. For example, if you are working on a medical science fair project then you may start to notice that the treatment is either working or not working for the population. You will need to make note about trends you are starting to see, yet you cannot draw any concrete conclusions on what this means, just yet.



Fourth Year Timeline Study



By the fourth year of your timeline study you will have a lot of data to work. If this is the designated end of your timeline study then you will need to do a more comprehensive analysis of your data. This analysis will need to establish clear trends in your data and you will need to explain why you got the results that you got. You may need to do additional research at this point to update the original background research that you did in year one.

The Days Of Starched White Medical Uniforms Are Long Gone


Today, wearing comfortable clothes is the first priority of working anywhere and nurses in particular need to wear tunics in which they are comfortable and can work freely. Nurses work 24/7, sometimes they also need to sleep in their uniforms , so it's important that the uniforms they wear are wrinkle free. Having the right uniform ensures that they can continue to focus on providing high quality care for the sick, injured and elderly to the best of their abilities.




Health and caring professionals notoriously work long hours, so it's essential that the medical uniforms they wear are capable of withstanding the everyday challenges of their working environments. This is where the choice of fabric plays a vital role. Garments constructed from a soft, breathable fabric are vitally important during long shifts as they provide comfort and enable the wearer to move freely. Uniforms must also be robust enough to withstand washes at high temperatures in order to reduce bacteria.



Each year, at least 100,000 people who go into hospital contract an infection there. Hospitals are hotbeds for deadly ‘superbugs' such as MRSA, so uniforms that are constructed from anti-bacterial fabric can help to protect against the growth of harmful bacteria by eliminating bacterial spores whilst the uniform is being worn. Anti-bacterial fabric is also designed to prevent body odour, so healthcare professionals continue to work in comfort however long their shifts.



Of course,tunics and uniforms don't just need to be practical, they need to create the right impression, too. Hospitals, surgeries and dental practices can often appear daunting to patients. Ensuring staff look and feel professional can go a long way to reassuring patients that they are in capable hands.



Colour can also play a vital role when it comes to caring for patients. Bright, bold uniforms are designed to ensure that staff are recognised by patients with degenerative diseases, such as Alzheimer's. In fact, research has shown that nurses wearing bright, multi-coloured uniforms make children feel more at ease and their parents more confident, therefore increasing their positive perceptions of nurses. Bold uniforms can also help to brighten up the predominantly sterile, white environments in which medical staff work.



Now more than ever, the medical profession has become trendy. Doctors and nurses have begun to wear their personality at work. Crisp, starched uniforms are out. Innovative designs providing comfort and professional quality are in. And wearing uniforms doesn't mean giving up a sense of style. Many of the new scrub styles have been inspired by the latest catwalk fashion trends borrowing their enticing colour palettes from high-end designer tops. In fact, they wouldn't look out of place if worn outside a medical environment. Medical science is constantly advancing – so too are Medical Uniforms.

Medicine In The Middle Ages


The Heptameron by Marguerite de Navarre is a representation of the French society in the middle ages. She has depicted various social and cultural norms of the time in the stories. Her insight into the science of medical practiced in France in the Middle Ages is quite apparent Even though the importance of medicine as specialty was acknowledged among the intellectuals of Paris; the influence of the church remained a conduit for its advancement. Although the supremacy of supernatural over natural was obvious, a clear implication was established that the natural and supernatural world was separate if not independent. As a result what we see is an amalgamation of medical science, mysticism and religion in the middle age France.




Ancient physiologists believed that the body must always have a balance of these humors, for imbalance will cause ailments. Diagnosis was based on examining sample of blood and also colors of skin, urine and feces.



Medical treatment by trained physicians rare and very expensive as a result the elite class could only afforded it. The uncertainty and unavailability of academic treatment left no choice for the general population, but to turn towards certain charms, special prayers and specific Christian rituals. Thirteen century Paris had only a half dozen doctors in public employ, with little time to spend on individual patients. Practice of medicine was not restricted to a certain sect of people rather clergy and laymen, men and women were all able to practice medicine.



The physician often compounded and dispensed drugs in addition to practicing medicine. And apothecary often engaged in medical practice as well as compounding and dispensing. It is evident from the stories in heptameron that the drugs made by apothecaries could be very lethal at times as they did not have the proper knowledge. Also personal hygiene was not an important factor for an apothecary, live alone the common people.



Diet was thought to be extremely important in the treatment of illness and prescriptions would cover the minutest of details for all sorts of conditions. The greatest general reliance was placed on broths, milk and eggs. Today the importance of diet in medical science is felt extensively. Nutrition as a special branch of study has emerged. Dietitians and nutritionist are there to help physicians in treating patients who needs special diets. Plants and herbs were used in the preparation of digestives, laxatives, emetics, diuretics, diaphoretics, styptics etc. Drugs remain to be the major form of treatments today but with the advanced technology, pharmacology has become one of the leading businesses.



Surgery a last resort advised by a physician but also it was only accessible to the wealthy. Surgery was known to be successful in cases of fistula, hemorrhoids, gangrene and cataracts. Bloodletting was one of the most common forms of surgery and was recommended for fever, inflammation, and a variety of disease condition and ironically for hemorrhages as well. There were three main methods of bloodletting during the middle ages: leeching, venesection and cupping. Among these leeching is still used, though rare as a medical procedure by some physicians. Leeching helps to reduce tissue congestion where arterial input is maintained but venous return is blocked or slowed leeches act as an extra vein to relieve a dangerous build-up of blood. As a result leech therapy is finding its way into numerous reconstructive surgeries such as digit and limb reattachment, skin graft procedure, scalp avulsions, and breast surgeries and even into effective treatment of periorbital hematomas. Anesthesia and pain relievers were available but some of the potions used were lethal in itself. For example the hemlock juice was used, and it could easily cause death.



The diseases that were very common in the Middle Ages were dysentery, jaundices pneumonia, influenza and common cold. This could be largely attributed to the living condition of that time. Rural people largely lived in a one-room structure with a central fire or hearth and a central roof with a small opening which allowed some of the smoke to escape. Homes were dark damp and cold, with minimum sunlight and poor air circulation, a perfect breeding place for germs and bacteria. The climatic conditions and life style of the time with no proper facilities contributed to the lack of personal hygiene as well. It further escalated with population growth in the towns and cities. Also due to lack of advanced techniques, patients often died due to excessive blood loss after a surgery. Today personal hygiene is considered to be a key factor to live a disease free life.



With the latest technologies available infant mortality has reduced and longevity of humans has increased tremendously compared to middle ages. As we benefit from the sophisticated technologies of medical science, it is imperative that we acknowledge the contribution of our predecessors. What we are enjoying today is the fruits from the trees whose seeds were planted by our ancestor